Skip to main content
SpringerLink
Log in

Sjögren’s Syndrome: Beyond Sicca Involvement

  • Chapter
  • First Online:
Autoimmune Diseases

Abstract

Sjögren syndrome (SS) is a systemic autoimmune disease that presents with sicca symptomatology of the major mucosal surfaces. The clinical spectrum of this condition often extends to systemic involvement (extraglandular manifestations) and may be complicated by the development of lymphoma. SS is one of the most prevalent autoimmune diseases (with an estimated 0.5–3 million sufferers in the United States), and primarily affects perimenopausal women. When sicca symptoms appear in a previously healthy ­person, the syndrome is classified as primary SS. This chapter summarizes recent work focused on extending and characterizing the acute and/or complex clinical presentations of patients with primary SS, including a wide variety of symptoms and the involvement of internal organs. As a general rule, the management of extraglandular features in primary SS should be targeted to the specific organ involved. The mainstays of such treatment regimens remain glucocorticoids and immunosuppressive agents. Such therapies are more likely to affect favorably the extraglandular manifestations of SS, even though the patients’ most intense complaints often pertain to sicca features. Severe, life-threatening involvement has rarely been reported in primary SS. There are now substantially more data on the outcome of patients with primary SS, which indicate that patients with a predominantly extraepithelial expression (often associated with cryoglobulinemia) should be monitored and managed differently from patients with a predominantly periepithelial or sicca-limited disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sjögren H. Zur kenntnis der keratoconjunctivitis sicca (keratitis filiformis bei hypofunktion der tränendrüsen). Acta Ophthalmol. 1933;11(suppl 2):1-151.

    Google Scholar 

  2. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med. 2004;164:1275-1284.

    Article  PubMed  Google Scholar 

  3. Helmick CG, Felson DT, Lawrence RC, National Arthritis Data Workgroup, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58:15-25.

    Article  PubMed  Google Scholar 

  4. Ramos-Casals M, Tzioufas AG, Font J. Primary Sjögren’s syndrome: new clinical and therapeutic concepts. Ann Rheum Dis. 2005;64:347-354.

    Article  PubMed  CAS  Google Scholar 

  5. Ramos-Casals M, Font J. Primary Sjögren syndrome. In: Imboden J, Hellman D, Stone JH, eds. Current Diagnosis & Treatment in Rheumatology. New York: McGraw-Hill; 2007:237-245.

    Google Scholar 

  6. Ramos-Casals M, Daniels TE, Fox RI, et al. Sjögren’s syndrome. In: Stone JH, ed. A Clinician’s Pearls and Myths in Rheumatology. London: Springer; 2009:107-130.

    Chapter  Google Scholar 

  7. Kamisawa T, Nakajima H, Egawa N, Funata N, Tsuruta K, Okamoto A. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology. 2006;6:132-137.

    Article  PubMed  CAS  Google Scholar 

  8. Ramos-Casals M, Anaya JM, García-Carrasco M, et al. Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients. Medicine. 2004;83:96-106.

    Article  PubMed  Google Scholar 

  9. McCauliffe DP, Faircloth E, Wang L, Hashimoto T, Hoshino Y, Nishikawa T. Similar Ro/SS-A autoantibody epitope and titer responses in annular erythema of Sjögren’s syndrome and subacute cutaneous lupus erythematosus. Arch Dermatol. 1996;132:528-531.

    Article  PubMed  CAS  Google Scholar 

  10. García-Carrasco M, Sisó A, Ramos-Casals M, et al. Raynaud’s phenomenon in primary Sjögren’s syndrome. Prevalence and clinical characteristics in a series of 320 patients. J Rheumatol. 2002;29:726-730.

    PubMed  Google Scholar 

  11. Nakamura H, Kawakami A, Hayashi T, et al. Anti-centromere antibody-seropositive Sjögren’s syndrome differs from conventional subgroup in clinical and pathological study. BMC Musculoskelet Disord. 2010;11:140.

    Article  PubMed  Google Scholar 

  12. Salliot C, Gottenberg JE, Bengoufa D, Desmoulins F, Miceli-Richard C, Mariette X. Anticentromere antibodies identify patients with Sjögren’s syndrome and autoimmune overlap syndrome. J Rheumatol. 2007;34:2253-2258.

    PubMed  CAS  Google Scholar 

  13. Tsokos M, Lazarou SA, Moutsopoulos HM. Vasculitis in primary Sjögren’s syndrome. Histologic classification and clinical presentation. Am J Clin Pathol. 1987;88:26-31.

    PubMed  CAS  Google Scholar 

  14. Molina R, Provost TT, Alexander EL. Two types of inflammatory vascular disease in Sjögren’s syndrome. Differential association with seroreactivity to rheumatoid factor and antibodies to Ro (SS-A) and with hypocomplementemia. Arthritis Rheum. 1985;28:1251-1258.

    Article  PubMed  CAS  Google Scholar 

  15. Ramos-Casals M, Loustaud-Ratti V, De Vita S, SS-HCV Study Group, et al. Sjögren ­syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine. 2005;84:81-89.

    Article  PubMed  Google Scholar 

  16. Ramos-Casals M, De Vita S, Tzioufas AG. Hepatitis C virus, Sjögren’s syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. Autoimmun Rev. 2005;4:8-15.

    Article  PubMed  Google Scholar 

  17. Ramos-Casals M, Sánchez-Tapias JM, Parés A, et al. Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjögren’s syndrome. J Rheumatol. 2006;33:1593-1599.

    PubMed  Google Scholar 

  18. Lindgren S, Manthorpe R, Eriksson S. Autoimmune liver disease in patients with primary Sjögren’s syndrome. J Hepatol. 1994;20:354-358.

    Article  PubMed  CAS  Google Scholar 

  19. Skopouli FN, Barbatis C, Moutsopoulos HM. Liver involvement in primary Sjögren’s ­syndrome. Br J Rheumatol. 1994;33:745-748.

    Article  PubMed  CAS  Google Scholar 

  20. Prince MI, Chetwynd A, Craig WL, Metcalf JV, James OF. Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort. Gut. 2004;53:865-870.

    Article  PubMed  CAS  Google Scholar 

  21. Abraham S, Begum S, Isenberg D. Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis. 2004;63:123-129.

    Article  PubMed  CAS  Google Scholar 

  22. Ramos-Casals M, Nardi N, Brito-Zerón P, et al. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases. Semin Arthritis Rheum. 2006;35:312-321.

    Article  PubMed  CAS  Google Scholar 

  23. Beswick DR, Klatskin G, Boyer JL. Asymptomatic primary biliary cirrhosis. A progress report on long-term follow-up and natural history. Gastroenterology. 1985;89:267-271.

    PubMed  CAS  Google Scholar 

  24. Goules A, Masouridi S, Tzioufas AG, Ioannidis JP, Skopouli FN, Moutsopoulos HM. Clinically significant and biopsy-documented renal involvement in primary Sjögren syndrome. Medicine. 2000;79:241-249.

    Article  PubMed  CAS  Google Scholar 

  25. Mellgren SI, Conn DL, Stevens JC, Dyck PJ. Peripheral neuropathy in primary Sjögren’s syndrome. Neurology. 1989;39:390-394.

    PubMed  CAS  Google Scholar 

  26. Font J, Ramos-Casals M, de la Red G, et al. Pure sensory neuropathy in primary Sjögren’s syndrome. Longterm prospective followup and review of the literature. J Rheumatol. 2003;30:1552-1557.

    PubMed  Google Scholar 

  27. Morozumi S, Kawagashira Y, Iijima M, et al. Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjögren’s syndrome. J Neurol Sci. 2009;279:57-61.

    Article  PubMed  CAS  Google Scholar 

  28. Chen WH, Yeh JH, Chiu HC. Plasmapheresis in the treatment of ataxic sensory neuropathy associated with Sjögren’s syndrome. Eur Neurol. 2001;45:270-274.

    Article  PubMed  Google Scholar 

  29. Gorson KC, Natarajan N, Ropper AH, Weinstein R. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial. Muscle Nerve. 2007;35:66-69.

    Article  PubMed  CAS  Google Scholar 

  30. Mori K, Iijima M, Sugiura M, et al. Sjögren’s syndrome associated painful sensory neuropathy without sensory ataxia. J Neurol Neurosurg Psychiatry. 2003;74:1320-1322.

    Article  PubMed  CAS  Google Scholar 

  31. Gorson KC, Ropper AH. Positive salivary gland biopsy, Sjögren syndrome, and neuropathy: clinical implications. Muscle Nerve. 2003;28:553-560.

    Article  PubMed  Google Scholar 

  32. Chai J, Herrmann DN, Stanton M, Barbano RL, Logigian EL. Painful small-fiber neuropathy in Sjögren syndrome. Neurology. 2005;65:925-927.

    Article  PubMed  CAS  Google Scholar 

  33. Gøransson LG, Herigstad A, Tjensvoll AB, Harboe E, Mellgren SI, Omdal R. Peripheral neuropathy in primary Sjögren syndrome: a population-based study. Arch Neurol. 2006;63:1612-1615.

    Article  PubMed  Google Scholar 

  34. de Seze J, Devos D, Castelnovo G, et al. The prevalence of Sjögren syndrome in patients with primary progressive multiple sclerosis. Neurology. 2001;57:1359-1363.

    PubMed  Google Scholar 

  35. Miro J, Pena-Sagredo JL, Berciano J, Insua S, Leno C, Velarde R. Prevalence of primary Sjögren’s syndrome in patients with multiple sclerosis. Ann Neurol. 1990;27:582-584.

    Article  PubMed  CAS  Google Scholar 

  36. Montecucco C, Franciotta DM, Caporali R, DeGennaro F, Citterio A, Melzi d’Eril GV. Sicca syndrome and anti-SSA/Ro antibodies in patients with suspected or definite multiple sclerosis. Scand J Rheumatol. 1989;18:407-412.

    Article  PubMed  CAS  Google Scholar 

  37. Metz LM, Seland TP, Fritzler MJ. An analysis of the frequency of Sjögren’s syndrome in a population of multiple sclerosis patients. J Clin Lab Immunol. 1989;30:121-125.

    PubMed  CAS  Google Scholar 

  38. Noseworthy JH, Bass BH, Vandervoort MK, et al. The prevalence of primary Sjögren’s syndrome in a multiple sclerosis population. Ann Neurol. 1989;25:95-98.

    Article  PubMed  CAS  Google Scholar 

  39. Delalande S, de Seze J, Fauchais AL, et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine. 2004;83:280-291.

    Article  PubMed  Google Scholar 

  40. Vrethem M, Ernerudh J, Lindström F, Skogh T. Immunoglobulins within the central nervous system in primary Sjögren’s syndrome. J Neurol Sci. 1990;100:186-192.

    Article  PubMed  CAS  Google Scholar 

  41. Saikali P, Cayrol R, Vincent T. Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica. Autoimmun Rev. 2009;9:132-135.

    Article  PubMed  CAS  Google Scholar 

  42. Nandhagopal R, Al-Asmi A, Gujjar AR. Neuromyelitis optica: an overview. Postgrad Med J. 2010;86:153-159.

    Article  PubMed  CAS  Google Scholar 

  43. Saiz A, Zuliani L, Blanco Y, et al. Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients. J Neurol. 2007;254:1233-1237.

    Article  PubMed  Google Scholar 

  44. Wingerchuck DM, Hogancamp WF, O’Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology. 1999;53:1107-1114.

    Google Scholar 

  45. Ramos-Casals M, Font J. Primary Sjögren’s syndrome: current and emergent aetiopathogenic concepts. Rheumatology. 2005;44:1354-1367.

    Article  PubMed  CAS  Google Scholar 

  46. Javed A, Balabanov R, Arnason BG, et al. Minor salivary gland inflammation in Devic’s disease and longitudinally extensive myelitis. Mult Scler. 2008;14:809-814.

    Article  PubMed  CAS  Google Scholar 

  47. Wandinger KP, Stangel M, Witte T, et al. Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjögren’s syndrome. Arthritis Rheum. 2010;62:1198-1200.

    Article  PubMed  CAS  Google Scholar 

  48. Pittock SJ, Lennon VA, de Seze J, et al. Neuromyeltis optica and non-organ-specific autoimmunity. Arch Neurol. 2008;65:78-83.

    Article  PubMed  Google Scholar 

  49. de Seze J, Delalande S, Fauchais AL, et al. Myelopathies secondary to Sjögren’s syndrome: treatment with monthly intravenous cyclophosphamide associated with corticosteroids. J Rheumatol. 2006;33:709-711.

    PubMed  Google Scholar 

  50. Alexander EL, Craft C, Dorsch C, Moser RL, Provost TT, Alexander GE. Necrotizing arteritis and spinal subarachnoid hemorrhage in Sjögren syndrome. Ann Neurol. 1982;11:632-635.

    Article  PubMed  CAS  Google Scholar 

  51. Sá MJ. Acute transverse myelitis: a practical reappraisal. Autoimmun Rev. 2009;9:128-131.

    Article  PubMed  Google Scholar 

  52. Ramírez M, Ramos-Casals M, Graus F. Central nervous system involvement in primary Sjögren syndrome. Med Clín. 2009;133:349-359.

    Article  Google Scholar 

  53. Shibata S, Ubara Y, Sawa N, et al. Severe interstitial cistitis associated with Sjögren’s syndrome. Intern Med. 2004;43:248-252.

    Article  PubMed  Google Scholar 

  54. Leppilahti M, Tammela TL, Huhtala H, Kiilholma P, Leppilahti K, Auvinen A. Interstitial cystitis-like urinary symptoms among patients with Sjögren’s syndrome: a population-based study in Finland. Am J Med. 2003;115:62-65.

    Article  PubMed  Google Scholar 

  55. Tumiati B, Casoli P, Parmeggiani A. Hearing loss in the Sjögren’s syndrome. Ann Intern Med. 1997;126:450.

    PubMed  CAS  Google Scholar 

  56. Ziavra N, Politi EN, Kastanioudakis I, Shevas A, Drosos AA. Hearing loss in Sjögren’s syndrome patients: a comparative study. Clin Exp Rheumatol. 2000;18:725-728.

    PubMed  CAS  Google Scholar 

  57. Boki KA, Ioannidis JP, Segas JV, et al. How significant is sensorineural hearing loss in primary Sjögren’s syndrome? J Rheumatol. 2001;28:798-801.

    PubMed  CAS  Google Scholar 

  58. Hatzopoulos S, Amoroso C, Aimoni C, Lo Monaco A, Govoni M, Martini A. Hearing loss evaluation of Sjogren’s syndrome using distortion product otoacoustic emissions. Acta Otolaryngol Suppl. 2002;54:20-25.

    Article  Google Scholar 

  59. Brito-Zerón P, Soria N, Muñoz S, et al. Prevalence and clinical relevance of autoimmune neutropenia in patients with primary Sjögren’s syndrome. Semin Arthritis Rheum. 2009;38:389-395.

    Article  PubMed  Google Scholar 

  60. Coppo P, Sibilia J, Maloisel F, et al. Primary Sjögren’s syndrome associated agranulocytosis: a benign disorder? Ann Rheum Dis. 2003;62:476-478.

    Article  PubMed  CAS  Google Scholar 

  61. Friedman J, Klepfish A, Miller EB, Ognenovski V, Ike RW, Schattner A. Agranulocytosis in Sjogren’s syndrome: two case reports and analysis of 11 additional reported cases. Semin Arthritis Rheum. 2002;31:338-345.

    Article  PubMed  CAS  Google Scholar 

  62. Friedman J, Schattner A, Shvidel L, Berrebi A. Characterization of T-cell large granular lymphocyte leukemia associated with Sjogren’s syndrome – an important but under-recognized association. Semin Arthritis Rheum. 2006;35:306-311.

    Article  PubMed  CAS  Google Scholar 

  63. Maheshwari A, Christensen RD, Calhoun DA. Immune-mediated neutropenia in the neonate. Acta Pediatr Suppl. 2002;438:98-103.

    Article  Google Scholar 

  64. Shastri KA, Logue GL. Autoimmune neutropenia. Blood. 1993;81:1984-1995.

    PubMed  CAS  Google Scholar 

  65. Bux J, Behrens G, Jaeger G, Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood. 1998;91:181-186.

    PubMed  CAS  Google Scholar 

  66. Vivancos J, Vila M, Serra A, Loscos J, Anguita A. Failure of G-CSF therapy in neutropenia associated with Sjögren’s syndrome. Rheumatology. 2002;41:471-473.

    Article  PubMed  CAS  Google Scholar 

  67. Ramos-Casals M, Font J, Garcia-Carrasco M, et al. Primary Sjögren syndrome: hematologic patterns of disease expression. Medicine. 2002;81:281-292.

    Article  PubMed  Google Scholar 

  68. Kyle RA, Rajkumar SV. Monoclonal gammopathies of undetermined significance. Rev Clin Exp Hematol. 2002;6:225-252.

    Article  PubMed  CAS  Google Scholar 

  69. Zandecki M, Genevieve F, Jego P, Grosbois B. Monoclonal gammopathies of undetermined significance. Rev Méd Interne. 2000;21:1060-1074.

    Article  PubMed  CAS  Google Scholar 

  70. Sugai S, Shimizu S, Konda S. Lymphoproliferative disorders in Japanese patients with Sjögren’s syndrome. Scand J Rheumatol Suppl. 1986;61:118-122.

    PubMed  CAS  Google Scholar 

  71. Walters MT, Stevenson FK, Herbert A, Cawley MI, Smith JL. Lymphoma in Sjögren’s ­syndrome: urinary monoclonal free light chains as a diagnostic aid and a means of tumour monitoring. Scand J Rheumatol Suppl. 1986;61:114-117.

    PubMed  CAS  Google Scholar 

  72. Brito-Zerón P, Ramos-Casals M, Nardi N, et al. Circulating monoclonal immunoglobulins in Sjögren syndrome: prevalence and clinical significance in 237 patients. Medicine. 2005;84:90-97.

    Article  PubMed  Google Scholar 

  73. Moutsopoulos HM, Steinberg AD, Fauci AS, Lane HC, Papadopoulos NM. High incidence of free monoclonal lambda light chains in the sera of patients with Sjögren’s syndrome. J Immunol. 1983;130:2663-2665.

    PubMed  CAS  Google Scholar 

  74. Sibilia J, Cohen-Solal J. Prevalence of monoclonal gammopathy and myeloma in a cohort of primary Sjögren’s syndrome. Arthritis Rheum. 1999;42(suppl 9):S140.

    Google Scholar 

  75. Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med. 2005;165:2337-2344.

    Article  PubMed  Google Scholar 

  76. García-Carrasco M, Ramos-Casals M, Cervera R, Font J. Primary Sjögren’s syndrome and lymphatic proliferation. Med Clín. 2000;114:740-746.

    Google Scholar 

  77. Hansen LA, Prakash UB, Colby TV. Pulmonary lymphoma in Sjögren’s syndrome. Mayo Clin Proc. 1989;64:920-931.

    PubMed  CAS  Google Scholar 

  78. Gentric A, Hervé JP, Cledes J, Pennec Y, Leroy JP. Renal insufficiency as a manifestation of lymphoma with acquired hypocomplementemia and Gougerot-Sjögren syndrome. Apropos of a case. Ann Méd Interne. 1987;138:668-669.

    CAS  Google Scholar 

  79. Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM. Malignant lymphoma in primary Sjögren’s syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren’s syndrome. Arthritis Rheum. 1999;42:1765-1772.

    Article  PubMed  CAS  Google Scholar 

  80. Ramos-Casals M, Brito-Zerón P. Emerging biological therapies in primary Sjögren’s ­syndrome. Rheumatology. 2007;46:1389-1396.

    Article  PubMed  CAS  Google Scholar 

  81. Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren’s syndrome. Arthritis Rheum. 2002;46:741-747.

    Article  PubMed  Google Scholar 

  82. Theander E, Manthorpe R, Jacobsson LT. Mortality and causes of death in primary Sjögren’s syndrome: a prospective cohort study. Arthritis Rheum. 2004;50:1262-1269.

    Article  PubMed  Google Scholar 

  83. Brito-Zerón P, Ramos-Casals M, Bove A, Sentis J, Font J. Predicting adverse outcomes in primary Sjögren’s syndrome: identification of prognostic factors. Rheumatology. 2007;46:1359-1362.

    Article  PubMed  Google Scholar 

  84. Ramos-Casals M, Tzioufas AG, Stone JH, Sisó A, Bosch X. Treatment of primary Sjögren syndrome: a systematic review. JAMA. 2010;304:452-460.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Autoimmune Diseases, Laboratory of Autoimmune Diseases Josep Font, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic, Barcelona, Spain

    Manuel Ramos-Casals

Authors
  1. Manuel Ramos-Casals
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pilar Brito-Zerón
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Albert Bové Boada
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Antoni Sisó-Almirall
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manuel Ramos-Casals .

Editor information

Editors and Affiliations

  1. Rayne Institute, Lupus Research Unit, St. Thomas' Hospital, London, SE1 7EH, United Kingdom

    Munther A. Khamashta

  2. Barcelona, Surgey, Hospital Clinic, Calle Villarroel, 170, Barcelona, 08036, Spain

    Manuel Ramos-Casals

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag London Limited

About this chapter

Cite this chapter

Ramos-Casals, M., Brito-Zerón, P., Boada, A.B., Sisó-Almirall, A. (2011). Sjögren’s Syndrome: Beyond Sicca Involvement. In: Khamashta, M., Ramos-Casals, M. (eds) Autoimmune Diseases. Springer, London. https://doi.org/10.1007/978-0-85729-358-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-358-9_5

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-357-2

  • Online ISBN: 978-0-85729-358-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation